Ravgen Sues Myriad Genetics Over Pre-Natal DNA Test Patents

Ravgen, a closely held maker of non-invasive DNA testing, said Myriad Genetics’ Prequel Prenatal Screen, Prelude Prenatal Screen and Informed Pregnancy Screen infringe two Ravgen patents for the technology.

• Ravgen is seeking cash compensation and either a court order blocking further unauthorized use of its inventions or a compulsory ongoing licensing fee, according to complaint filed Monday but not yet docketed in federal court in Wilmington, Delaware
• Ravgen earlier in December sued Illumina and Roche over the same patents, having already filed lawsuits against Natera, PerkinElmer and LabCorp; the cases, in Delaware and Texas federal courts, ...